It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2021.
2021 | Mumbai, Maharashtra, India | ActiveTaiyo Pharma Research & Development Private Limited, a active private limited company, was established on 26 November 2021 in Mumbai, Maharashtra, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230MH2021PTC372331. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Chrisann Sequeira (Director), Kunal Vijay Bhatt (Director). Past directors included Arjun Sanjay Patel, Jesal Parag Thakkar. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at C-2012A, Kailash Business Park, Vikhroli (W), Park Side Road, Mumbai, Maharashtra, 400079.
U24230MH2021PTC372331
372331
26 November 2021
₹2.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Taiyo Pharma Research & Development Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chrisann Sequeira | Director | 26 Nov 2021 | Current |
| Kunal Vijay Bhatt | Director | 26 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 May 2023 | Past |
| Pramod Abcsdd | Director | 05 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Taiyo Pharma Research & Development's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Taiyo Pharma Research & Development's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Taiyo Pharma Research & Development has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Taiyo Pharma Research & Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taiyo Pharma Research & Development's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Taiyo Pharma Research & Development Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Taiyo Pharma Research & Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was recorded as a recent event.
Progress on Chrisann Sequeira was appointed as a Director was appointed as a Director on 26 Nov 2021 & has been associated with this company since 4 years 2 days . was documented.
Progress on Kunal Vijay Bhatt was appointed as a Director was appointed as a Director on 26 Nov 2021 & has been associated with this company since 4 years 2 days . was documented.
Taiyo Pharma Research & Development Private Limited was registered on 26 Nov 2021 with Roc Mumbai & aged 4 years 2 days as per MCA records. was recorded as a recent event.
The CIN of Taiyo Pharma Research & Development Private Limited is U24230MH2021PTC372331.
Taiyo Pharma Research & Development Private Limited is headquartered at C-2012A, Kailash Business Park, Vikhroli (W), Park Side Road, Mumbai, Maharashtra, 400079.
Taiyo Pharma Research & Development Private Limited was incorporated on 26 November 2021.
The current directors of Taiyo Pharma Research & Development Private Limited are
The primary industry of Taiyo Pharma Research & Development Private Limited is Chemicals.
Taiyo Pharma Research & Development Private Limited is unlisted.
The authorized capital of Taiyo Pharma Research & Development Private Limited is ₹2.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX